Skip to main content
. 2020 Apr 9;106(4):1129–1137. doi: 10.3324/haematol.2019.243238

Table 2.

Adverse events grade 3 or 4 during brentuximab vedotin and dexamethasone, high-dose cytarabine and cisplatin, high-dose cytarabine, cisplatin.

graphic file with name 1061129.tab2.jpg